Get more replies from employers
Send a job-specific resume in minutes.
Novo Nordisk A/S in Søborg, Denmark, is seeking a Senior Safety Surveillance Advisor to contribute strategic safety input for post-marketing activities across the incretin portfolio. You will partner with Regulatory Affairs and other functions to drive safety messaging and risk management decisions.
You will lead medical evaluations, risk evaluations, and signal assessments while ensuring high-quality regulatory submissions and external communications to Health Authorities.
Location:
Søborg, Capital Region of Denmark, DK
Do you want to influence key safety decisions for some of Novo Nordisk's most important products? Are you motivated by combining scientific expertise, strategic thinking and stakeholder collaboration to help protect patients worldwide?
We are looking for a Senior Safety Surveillance Advisor to join our Safety Surveillance Post-Marketing team. Apply today and become part of a science-driven organisation dedicated to improving patient safety.
We are seeking an experienced professional to contribute to high-impact activities across the incretin portfolio. In this role, you will be responsible for providing strategic safety input to post-marketing activities and acting as a trusted safety partner to key stakeholders. We offer a dynamic and rewarding opportunity within a leading global healthcare company.
Key responsibilities include:
You will have the opportunity to work both independently and through others, in close collaboration with highly skilled, committed, and enthusiastic colleagues. You will establish strong partnerships with key functional areas across Novo Nordisk, particularly Regulatory Affairs. We expect sound scientific judgement, a strong focus on quality, and a proactive approach to driving initiatives and influencing outcomes.
Safety Surveillance Post-Marketing is an area within Global Patient Safety and is based in Søborg, Denmark. We also have a department in Bangalore, India. Our dedicated and skilled professionals have global responsibility for Novo Nordisk's portfolio of marketed products. The area consists of seven teams across Denmark and India.
In the Post-Marketing Cardiometabolic I team, we manage safety signals for all semaglutide products once they are detected. We chair the Novo Nordisk Safety Committee, lead external communication related to safety signals, and provide timely safety input to key projects. In addition, we provide strategic input to aggregate reports, including PSURs, DSURs and RMPs, as well as responses to Health Authorities, recognising these deliverables as strategic assets that directly influence regulatory outcomes and Novo Nordisk's external credibility.
We work closely with colleagues across Safety Medical Writing, Regulatory Affairs, Medical and Translational Science, Global Medical Affairs, and Biostatistics.
We value a positive and inclusive team culture and count on you to contribute to and strengthen this collaborative spirit.
As an ideal candidate, you have:
As a person, you combine scientific judgement with a pragmatic, data-driven approach to decision‑making. You thrive in a dynamic environment, confidently navigating changing priorities and ambiguity while maintaining a high level of quality and accuracy. You communicate effectively with diverse stakeholders and balance strategic thinking with a hands‑on approach to delivering results.
At Novo Nordisk, you'll join a global healthcare company with a unique culture and strong results. We offer continuous learning, career development, and benefits tailored to your life and career stage.
Salary: For this role, the Annual Base Salary ranges from 651,000.00 to 956,900.00 DKK, corresponding to the level of the position.
The placement within the salary range will be assessed during the recruitment process based on the candidate's skills, competencies, knowledge, and relevant experience.
Incentives and Benefits: The salary package may include short-term and/or long-term incentives as well as other employee benefits based on position level, location, functional area and relevant market benchmarks.
Learn more about our Reward Philosophy here.
9 August 2026
Applications will be reviewed on an ongoing basis, so we encourage you to apply as soon as possible.
We commit to an inclusive recruitment process and equality of opportunity for all our job applicants.